Bachelor's degree in Accounting, Finance, or related discipline; CPA required; Big Four experience preferred.
10+ years of progressive accounting experience, including at least 3 years leading teams in a publicly traded biotech or life sciences company.
Hands-on experience in operational accounting, including public-company accounting operations and SEC reporting.
Proficiency with ERP and accounting systems; advanced Excel skills; experience with NetSuite, Coupa, Concur, ADP, E-Trade, and Active Disclosure.
Proven ability to develop teams and influence cross-functional partners in a lean environment.
Responsibilities
Own the monthly, quarterly, and annual close, ensuring compliance with U.S. GAAP.
Oversee accounting for Clinical/R&D accruals, prepayments, and program-level expenses.
Manage SEC filings, ensuring compliance with disclosure requirements; familiarity with Active Disclosure preferred.
Lead the equity compensation program and stock-based compensation accounting.
Collaborate with Clinical Operations and FP&A to establish supportable accruals for contracts and vendors.
Lead SOX and internal control activities, including risk assessment and documentation.
Serve as the primary contact for external and internal auditors, coordinating audit support.
Benefits
Flexible work arrangements to promote work-life balance.
Professional development opportunities and mentorship programs.
Comprehensive health and wellness benefits.
Participation in the company's equity compensation program.
Collaborative and innovative work environment.
Full Job Description
The Assistant Controller/Controller (consultant role) will oversee the maintenance of the Company's financial and accounting departments. This is a hands-on role for a technically strong accounting professional who can navigate complex biotech transactions, manage a team, and improve processes in a lean organization. The Assistant Controller/Controller (Consultant role) will partner across Finance and the business, balancing public-company rigor with practical, efficient execution.
Responsibilities
Own the monthly, quarterly, and annual close, reconciliations, and internal management reporting; ensure accurate and complete accounting records in accordance with U.S. GAAP.
Oversee the accounting components of Clinical/R&D accruals, prepayments, commitments, and program-level expenses, including review of estimates, journal entries, reconciliations, and true-ups.
Own and review SEC filings (Forms 10-K, 10-Q, and 8-K, and proxy statements), ensuring compliance with applicable SEC disclosure requirements; proficiency in Active Disclosure or a similar reporting platform is preferred.
Lead the Company's equity compensation program and stock-based compensation accounting, including option, RSU, and ESPP activity, ASC 718 accounting, and common share/equity pool reconciliations.
Partner with Clinical Operations, Technical Operations, and FP&A to establish supportable accruals for contract research organizations, contract manufacturers, and investigator sites using contracts, operational progress, and vendor data.
Lead SOX and internal control activities within accounting, including risk assessment, documentation, testing, and remediation.
Support management assessments and external auditor attestation under SOX Section 404.
Partner with IT and business process owners on access, segregation of duties, and related controls.
Serve as the primary accounting contact for external and internal auditors; coordinate audit and quarterly-review support for accounting operations and SOX testing.
Oversee payroll and employee benefits accounting, including review of payroll-related journal entries, accrued compensation, bonuses, stock-based compensation, and employee benefit costs
Manage the Company's corporate insurance programs, including policy renewals, coverage reviews, premium negotiations, coordination with brokers and insurance carriers, and ensuring appropriate coverage for the Company's evolving business needs.
Oversee General Ledger, Accounts Payable, disbursements, fixed assets, and expense processes.
Maintain effective invoice processing, payment-approval, and disbursement controls.
Support income tax provision and compliance activities by providing accurate accounting records and schedules to the responsible internal teams and external advisors.
Lead, mentor, and develop the accounting team and manage accounting service providers.
Establish clear accountability, cross-training, and professional development opportunities.
Partner with Finance team to provide reliable actuals, accruals, and insights for budgeting, forecasting, cash planning, and liquidity assessments.
Provide accounting analysis and due diligence support for financing, partnerships, and other corporate transactions. Communicate complex issues clearly and raise risks early with practical recommendations.
Qualifications
Bachelor's degree in Accounting, Finance, or related discipline; CPA required; Big Four experience preferred.
10+ years of progressive accounting experience, including at least 3 years leading teams and significant experience within a U.S. publicly traded biotechnology or life sciences company.
Prior hands-on experience in an operational accounting role, including direct responsibility for leading public-company accounting operations, the financial close, preparation of accounting analyses, SEC reporting, audit support, and SOX compliance.
Proficiency with ERP and accounting and payroll systems; advanced Excel skills and a track record of improving close, accrual, and internal reporting processes and data quality. Proficient in NetSuite, , Coupa, Concur, ADP, E-Trade and Active Disclosure (or other similar platforms).
Demonstrated success developing teams and influencing cross-functional partners in a lean environment. Strong analytical and communication skills, sound judgment, integrity, and the confidence to challenge assumptions and uphold accounting standards.
About Biomea Fusion
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing transformative therapies to treat patients with cancer. Biomea Fusion's lead product candidate, BMF-219, is an oral, selective inhibitor of the fusion of NTRK1, NTRK2, and NTRK3 genes, which is in Phase 1/2 clinical trial for adult patients with solid tumors harboring an NTRK gene fusion. The Company is also developing BMF-119, a selective inhibitor of the fusion of MET exon 14 and other MET alterations. Biomea Fusion, Inc. is based in Brisbane, California.
